JoVE - Journal of Visualized Experiments
JoVE Visualize
Contact Us

Small for Size Syndrome in Living Donor Liver Transplantation- Prevention and Management

  • 0Star Institute for Advanced Liver Care & Transplantation, Star Hospitals, Hyderabad, Rainbow Children's Hospital, Hyderabad, India.
Journal of Clinical and Experimental Hepatology +

|

December 26, 2024

|

December 26, 2024

View abstract on PubMed

Summary

This summary is machine-generated.

Small-for-size syndrome, a complication of liver transplantation, arises from a graft size mismatch. Management focuses on patient care and preventing complications, with retransplantation as a last resort for severe cases.

Area Of Science

  • Hepatology
  • Transplantation Surgery
  • Clinical Medicine

Background

  • Small-for-size syndrome (SFS) is a critical complication in living donor liver transplantation (LDLT).
  • It results from an inadequate graft size relative to the recipient's metabolic demands, leading to early allograft dysfunction.
  • While graft size is a primary predictor, SFS is multifactorial, involving modifiable and non-modifiable factors.

Purpose Of The Study

  • To review the understanding and management of small-for-size syndrome in liver transplantation.
  • To highlight the multifactorial nature of SFS beyond simple graft size mismatch.
  • To discuss current management strategies and areas needing further research.

Main Methods

  • Review of existing literature on small-for-size syndrome in liver transplantation.
  • Analysis of factors contributing to SFS development and progression.
  • Discussion of clinical management approaches and outcomes.

Main Results

  • Small-for-size syndrome is characterized by early allograft dysfunction post-liver transplant.
  • It is influenced by a complex interplay of factors, not solely graft size.
  • Intraoperative portal hemodynamics and flow modulation are important but inconsistently applied.
  • Management involves intensive patient care, infection control, and fluid balance.
  • Retransplantation is the definitive treatment for severe SFS.

Conclusions

  • Small-for-size syndrome significantly increases peri-operative mortality in liver transplant recipients.
  • Effective management requires meticulous patient care and addressing modifiable factors.
  • Further research is needed to understand the impact of non-hepatic organ failure on patient outcomes in SFS.

Keywords: